Just to be in par of its peer should see price around $30 ~ $80! Hello Wall Street! Hello Main Street!
1st interim results will be announced any time from now to June, followed 2nd interim results and final results!
Man, he just gave a rough analysis which everybody understands. BTW, he only includes the US in his analysis. If US, UK, Germany, etc. are all included, how huge would be that potential?
I don't know why people stick to $1 or $2 difference. Nothing is perfect and absolute. We only need to understand the essence at this stage!
The most powerful stock price analysis is simply to compare companies in the same group or area in combination with each individual company's specifics.
NWBO is well ahead of its peer in terms of development stage, manufacturing capability, and best of the peer clinical results;
and yet its market cap is indeed only a tiny fraction of its peer.
Thank God, the Wall Street has finally paused and looked at us!
Without final ph3 results, nwbo's share price should be at least in par with its peer, either $71, $42, $60 or $45, and the price should be somewhere from $100 ~ $1000 by taking into account the full potentials of both DCVax-L and DCvax-D!
When the trial is stopped, there is instant 5 billion dollar market cap!
We have only realized 1/3 ~ 1/5 the values of our peers with more advanced trials and manufacturing process and much higher targeted patient population!
It is on Monday from 1~5pm. There should be lots of data to digest! After that with further market awakening, shorts may start to give up!
The various potential catalysts have not yet been realized so it may just be the beginning.
I like that numerous catalysts are now concentrated in the near future: detailed data for both L and D, HE price announcement, final UK designation for early commercial use, partnership deal, interim results, etc.
Let them come in aggregate!
I forget perhaps one powerful catalyst is the collapse of shorts. As someone said, don't be the last one to exit the door!
More data will be released on 20 April! Go NWBO go!
Maybe the good news is coming from 1st interim analysis and DMC's recommendation of stop for efficacy. It could happen any time from now to June!